Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Efficacy of vestipitant, a neurokinin-1 receptor antagonist, in primary insomnia.
Journal: Sleep
Published: December 03, 2013
Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies.
Journal: Journal of psychopharmacology (Oxford, England)
Published: March 30, 2013
Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials.
Journal: Journal of psychopharmacology (Oxford, England)
Published: November 04, 2011
Results from 2 randomized, double-blind, placebo-controlled studies of the novel NK1 receptor antagonist casopitant in patients with major depressive disorder.
Journal: Journal of clinical psychopharmacology
Published: October 25, 2011
Showing 1-4 of 4
Last Updated: 09/26/2026